Best Alzheimer's and Dementia Research Grants in South Dakota

The McKnight Brain Research Foundation Innovator Awards aim to support innovative research in cognitive aging and memory loss, offering two 3-year grants of $750,000 each. Targeted at early-career investigators, the program encourages high-risk, high-gain proposals that explore clinical translational research and the biological mechanisms of cognitive aging. By fostering emerging scientific leaders, the initiative seeks to advance transformative discoveries in this critical area of aging research, enhancing understanding and treatment of age-related cognitive decline.

The JTMF Foundation Grant focuses on improving the lives of individuals in need, particularly in the Pacific Northwest. By partnering with organizations addressing immediate needs and long-term challenges, the foundation supports children, older adults, veterans, and individuals with intellectual and developmental disabilities. Guided by Catholic values, JTMF aims to empower communities while seeking innovative solutions to societal issues. Organizations that align with these focus areas are encouraged to connect, fostering a collaborative effort towards meaningful impact.

South Dakota dementia and Alzheimer’s organizations can access funding through Alzheimer’s Foundation of America’s bi-annual grant program. AFA nonprofit member organizations in good standing may receive US $6,000 for new or existing programs, including administrative costs, staff salaries and training, occupancy, and supplies that support individuals, families, and caregivers affected by Alzheimer’s and related dementias.

Universities, research institutions, and similar organizations in South Dakota can access funding to provide intensive postbaccalaureate research education experiences in Alzheimer’s and Alzheimer’s disease-related dementias. US Dept. of Health & Human Services: National Institutes of Health supports one-to-two-year mentored research and professional development programs, with awards up to US $400,000 for AD/ADRD projects related to aging.

With a mission to expand Alzheimer’s and dementia research education, the National Institutes of Health provides South Dakota research institutions and education-focused organizations with up to US $200,000 for summer programs. Funding supports hands-on AD/ADRD research experiences and enrichment activities for high school students, undergraduates, or science teachers to build the future dementia research workforce.

South Dakota Alzheimer’s and dementia researchers, particularly early-career assistant professors (or equivalent) within seven years of appointment, can access funding through the Alzheimer’s Association to advance dementia and Alzheimer’s disease research. The AARGA program offers US $70,000 - US $200,000 for pilot or preliminary projects across basic, translational, clinical, psychosocial, or care-focused studies, open to U.S. and international applicants.

South Dakota nonprofits supporting dementia and Alzheimer’s care can access funding through Sephardic Home For The Aged Foundation to improve quality of life for older adults. Eligible 501(c)(3) organizations (or those with a fiscal sponsor) operating at least two years may propose innovative programs addressing dementia care and related brain degenerative diseases.

Postdoctoral researchers working on dementia and Alzheimer’s disease in South Dakota can seek funding to advance understanding, diagnosis, or treatment. The Alzheimer’s Association supports early career investigators globally through its Research Fellowship for All (AARFA) Program, offering up to US $200,000 and encouraging applications from individuals from underrepresented groups.

Clinician scientists conducting dementia and Alzheimer’s disease research, including those based in South Dakota, can access funding through the Alzheimer’s Association Clinician Scientist Fellowship for All program. Grants up to US $250,000 support licensed, practicing clinicians in patient-contact or diagnostic fields, with individuals from underrepresented groups especially encouraged to apply.

With a mission to support those affected by dementia, Alzheimers Foundation of America provides South Dakota Alzheimer’s-focused nonprofits with US $25,000 for innovative programs improving life for individuals with Alzheimer’s or related illnesses and their families. Only AFA nonprofit member organizations may apply, and funds can cover program-related staff, administration, training, occupancy, supplies, and equipment.

Public safety agencies running dementia wandering-prevention and safety programs in South Dakota can apply for funding to cover training, equipment, administration, and community outreach. Focused on dementia and Alzheimer’s disease, the Alzheimer’s Foundation of America invites eligible Project Lifesaver International member agencies to seek US $6,000 grants, awarded twice yearly, to strengthen local public safety efforts.

Nonprofit organizations providing dementia and Alzheimer’s respite care in South Dakota can apply for the Milton & Phyllis Berg Family Respite Care Grants from the Alzheimer’s Foundation of America; awards US $6,000 for respite care scholarships. Funding may cover supplies, equipment, capacity building, administrative expenses, and staff training to better support caregivers and families.

Researchers and research institutions conducting imaging studies on Alzheimer’s and other neurodegenerative diseases can apply for funding to advance novel imaging tools and data analysis. Grants from the Alzheimer’s Association help South Dakota dementia and Alzheimer’s disease researchers access up to US $200,000 for early-stage pilot imaging projects over one year.

Researchers studying aging, Alzheimer’s disease, or related dementias in South Dakota can apply for National Institute on Aging R01 funding to investigate mechanisms linking olfactory decline with these conditions. Focused on circuit-level and mechanistic work, projects may use human older adults or animal models and diverse cellular, molecular, imaging, physiological, or omics approaches.

South Dakota Alzheimer’s and dementia researchers can apply for funding to study cerebellar contributions to cognitive and affective functions in healthy aging and in Alzheimer’s disease and related dementias. Focused on cerebellar physiology, neuroanatomy, data analyses, and intervention targets, the National Institutes of Health will support R01 projects using human or animal models and existing datasets.

Families needing in-home respite care for loved ones with Alzheimer’s or other dementias can apply for the Margaret B. Moeller Memorial Fund, which awards US $200 - US $3,000 to pay for home care companions, aides, or similar support. Although the fund serves the Boyertown Area School District, South Dakota caregivers may find this model informative.

South Dakota Alzheimer’s and dementia research organizations conducting preclinical drug discovery may be eligible for this upcoming opportunity supporting novel therapeutic targets. Local dementia and aging researchers can access funding through the National Institutes of Health to validate Alzheimer’s and related dementia targets and advance early-stage small molecule, biologic, or emerging therapeutic candidates.

Research institutions studying mechanisms of neurodegeneration in Alzheimer’s disease-related dementias in South Dakota and nationwide can apply for collaborative “Center without Walls” consortia funding; awards support ambitious, multi-institutional basic and clinical research. National Institutes of Health, through NINDS, anticipates supporting interdisciplinary teams using advanced technologies, disease-relevant models, and human specimens to uncover novel ADRD mechanisms and therapeutic targets.

Nonprofit research institutions studying neuroscience and Alzheimer’s disease-related dementias can seek funding to investigate how exposomic factors affect ADRD pathology and resilience, including work relevant to South Dakota. National Institutes of Health supports mechanistic, translational, and human subjects research on environmental toxins, sleep, stress, and related pathways across the lifespan, excluding NIH-defined clinical trials.

Research institutions and teams studying dementia and Alzheimer’s disease in South Dakota can apply for National Institutes of Health funding to functionally validate new therapeutic targets. This phased award supports technology and model development, then rigorous cross-validation of target modulation effects to de-risk future translational research on Alzheimer’s disease–related dementias.

Research institutions and affiliated organizations in South Dakota studying dementia and Alzheimer’s care pathways or early detection can apply for the Alzheimer’s Association’s Health Services Research in Alzheimer’s Disease and Related Disorders program, with awards up to US $250,000. Funding supports rigorous health services research on detection, diagnosis, and post-diagnostic dementia care.

The NIH Blueprint for Neuroscience Research Network aims to enhance foundational research on human consciousness, addressing critical biomedical issues such as coma and dementia. By fostering a collaborative framework among 14 NIH institutes, the initiative seeks to improve diagnosis and treatment of neurological disorders through interdisciplinary approaches. Key objectives include detecting consciousness in minimally responsive patients, enhancing understanding of sleep disorders, and exploring new methodologies. This effort will ultimately strengthen U.S. leadership in neuroscience and improve patient outcomes.

The DoW Alzheimer’s Transforming Research Award supports innovative research aimed at reducing the risk and preventing Alzheimer’s disease and related dementias. It emphasizes projects that enhance understanding of risk factors and develop effective risk reduction strategies. Clinical research is permitted, but trials and animal studies are not. Collaboration and preliminary data are essential for proposal consideration, and an option for multiple principal investigators is available to foster partnerships.

The FY26 Alzheimer’s Research Program's Transforming Diagnosis Award (TrDA) promotes innovative research aimed at overcoming significant barriers to accurate diagnosis and monitoring of Alzheimer's disease. This award encourages community collaboration and requires preliminary data. It supports studies leveraging existing cohorts, especially those including individuals aged 65 and younger. The TrDA also offers a partnership option for multiple principal investigators, fostering collaborative research efforts while ensuring at least one independent investigator meets eligibility criteria.

The DoW Alzheimer’s Transforming Care Award aims to support innovative clinical research and trials enhancing dementia care for individuals with Alzheimer’s disease. This funding opportunity encourages collaborative partnerships and requires preliminary data, focusing on interventions that do not solely test pharmacological solutions. Community collaboration is essential, and studies leveraging existing cohorts, including those with younger participants, are encouraged. The award supports both new and existing partnerships among principal investigators.

The NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) aims to create a secure, scalable cloud platform for genetic data related to Alzheimer’s disease. This initiative will enhance data accessibility, promote interoperability, and support rigorous research practices. By facilitating collaboration and providing robust analytical tools, the platform will maximize the scientific impact of AD/ADRD research, aligning with NIH goals for transparent and reproducible science, while addressing recommendations for broad access to high-value datasets.

Researchers and early-career scientists studying Alzheimer’s disease can apply for BrightFocus Foundation’s international research grants, including applicants based in South Dakota, with awards of US $200,000 - US $300,000 for pioneering projects. Funding supports both standard awards for new investigators and postdoctoral fellowships in their final mentored training stages.